Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gammora in Addition to Standard Antiretroviral Treatment for HIV Infection
NCT06799650Phase 2Active, not recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Jan 2025
- Primary completion
- Nov 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Codivir in human immunodeficiency virus infection (HIV), sponsored by Federal University of São Paulo. Started Jan 2025; status: active, not recruiting.
02
Drugs
Codivir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT06799650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06799650.